• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Carfilzomib
Ibuprofen Arginine
Uridine 5’-triphosphate trisodium salt（UTP-Na3）
Uridine 5’-diphosphate disodium salt（UDP-Na2）
Semaglutide
Uridine 5’-monophosphate disodium salt（UMP-Na2）

Lupin launches generic Namenda XR capsules in the US

biospectrumasiaFebruary 26, 2018

Tag: lupin , US , Namenda XR capsules

Pharma major Lupin announced the launch of its Memantine Hydrochloride Extended-Release Capsules, 7mg, 14mg, 21mg, 28mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Memantine Hydrochloride ER capsules 7mg, 14mg, 21mg, 28mg are the generic equivalents of Allergan’s Namenda XR® capsules. It is indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.

Memantine Hydrochloride ER capsules 7mg, 14mg, 21mg, 28mg had annual sales of approximately USD 936 million in the US (IQVIA MAT December 2017).

Register as Visitor to CPhI China 2018!

Previous:Merck invests additional €40 M to enhance services in Asia

Next:PharmaJet unites with Genexine to develop DNA vaccine

Related News

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Manulife Hong Kong today announced a new partnership with New Frontier Group, one of the leading healthcare service providers in Greater China, to introduce cashless services for eligible customers through New Frontier Group's subsidiary, Prosper Health.

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Lupin launches generic Namenda XR capsules in the US | Pharmasources.com

Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

PRNewswireDecember 13, 2024

Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis

You may like
More>>

Halal Acorus Calamus Extract Powder 10:1

Halal Acorus Calamus Extract Powder 10:1
Glucose Intravenous Infusion

Glucose Intravenous Infusion
Customizable Cleaning Cloth

Customizable Cleaning Cloth

Phosphorus Acid

Phosphorus Acid
Tea Tree mushroom Extract Agrocybe chaxinggu

Tea Tree mushroom Extract Agrocybe chaxinggu
Glycine Industrial Grade Supplier

Glycine Industrial Grade Supplier

Food Grade Dipotassium Phosphate Anhydrous 98% CAS 7758-11-4

Food Grade Dipotassium Phosphate Anhydrous 98% CAS 7758-11-4
Sphaeranthus indicus L

Sphaeranthus indicus L
Linbel DLSB-50/40 Cooling Laboratory Circulator Industrial Chiller Pump

Linbel DLSB-50/40 Cooling Laboratory Circulator Industrial Chiller Pump
Fructus Monordicae extractLuo Han Guo Extract Momordica Grosvenori ExtractMomordica extract Momordic

Fructus Monordicae extractLuo Han Guo Extract Momordica Grosvenori ExtractMomordica extract Momordic

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service